Altamira Therapeutics Ltd (FRA:2QA)
€ 948 0 (0%) Market Cap: 1.45 Mil Enterprise Value: 1.79 Mil PE Ratio: 0.84 PB Ratio: 0.17 GF Score: 28/100

Altamira Therapeutics Ltd to Host Investor & Business Update Call Transcript

Dec 11, 2023 / 01:30PM GMT
Release Date Price: €948
Operator

Good morning, and welcome to Altamira Therapeutics December 23, 2023, investor business update conference call. On today's call is Thomas Meyer, Altamira Therapeutics, Founder, Chairman, and Chief Executive Officer. Earlier today, Altamira issued a news release providing a highlight of its business activities, which will be -- we will be discussing on this call. The release is available on the company's website at ir.altamiratherapeutics.com, and that's been filed with the SEC.

During today's call, the company will be making forward-looking statements within the meanings of the Private Securities Litigation Reform Act of 1995. These include statements that address future operating financial business performance, strategies or expectations. Forward looking statements are based on the company's current expectations and beliefs and involve significant risks and uncertainties that could cause actual results, developments and business decisions to differ materially from those contemplated by these statements.

These risks and uncertainties include, but are not limited to, the timing and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot